Biocept Inc said it has granted inducement stock options to purchase an aggregate of 89,550 shares of its common stock to 12 new employees. The inducement stock options have a grant date of August 31, 2022, and were granted as inducements material to the new employees entering into employment with Biocept in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement stock options have an exercise price of $1.03 per share, the closing price of Biocept's common stock on August 31, 2022, are non-qualified stock options, have a ten-year term and vest over four years, with 25% of the shares vesting on the one-year anniversary of the vesting commencement date and the remaining 75% of the shares vesting in equal monthly installments over the following 36 months, subject to the new employees' continued service with Biocept through the applicable vesting dates. The inducement stock options are subject to the terms and conditions of Biocept's Amended and Restated 2013 Equity Incentive Plan, as amended.
Bloom Health Partners Inc has reported a significant jump in revenue for fiscal 3Q, nearly reaching its full-year revenue guidance in just three quarters. Bloom CEO Andrew Morton said the company’s 3Q revenue of C$8.4 million and aggregate C$24.9 million for the year-to-date has resulted in the company all but reaching its revenue guidance for the 2022 financial year of C$25 million to C$28 million with one quarter left to go. “We're proud of our team's performance so far this year as we continue to transition Bloom into an innovative provider of employer health-tech solutions and services,” he said.
Todos Medical Ltd said it has entered into a lease agreement for a 15,200-square-foot botanical supplement manufacturing facility on a 6-acre lot located in the Dallas-Fort Worth area of Texas. The facility is equipped with botanical extraction, distillation and finished good production capabilities, including $2 million of botanical manufacturing equipment. That makes it capable of producing Tollovid, the protease inhibitor immune support dietary supplement, as well as other immune support supplement ingredients such as vitamin C and CBD-A.
Broker Stifel GMP is upbeat on Mongolia-focused miner Steppe Gold Ltd and expects its shares to re-rate as the company continues to execute steady production at its flagship ATO mine. On August 30, Steppe reported positive progress on its Phase 2 expansion plan at the mine after it received a landmark power agreement and is constructing a new fixed crusher, which is expected to be completed in October this year. The installation is 72% complete and, once operational, the new unit will increase Steppe's current processing capacity by four times, up to 4 million tonnes per annum at 50% of its power. Stifel rates Steppe a 'Buy' and targets C$2.90 a share (current price: C$1.10).
PlantX Life Inc has announced the continuation of its successful live event initiative to support the company's retail locations and to bolster its growing reputation as the leader in the plant-based lifestyle. Over the past weekend, PlantX said it hosted events at the Peter Rubi store on Montrose Avenue and at the XMarket Uptown store, both in Chicago, to drive traffic as well as to promote a healthy plant-based lifestyle. "This past weekend's live vegan event activations were a huge success for PlantX and our brand partners," said PlantX CEO Lorne Rapkin in a statement. "At both Chicagoland locations, we drove a measurable impact on the sell-through of these great products and a lift in store sales overall at both locations."
American Manganese Inc, doing business as RecycLiCo Battery Materials, said its advanced battery recycling and upcycling process has the potential to produce lower levels of carbon-dioxide (CO2) equivalent emissions when producing lithium hydroxide monohydrate (LHM) compared with traditional methods. The findings were reported in a life cycle assessment (LCA) completed by Minviro Ltd, a UK-based and globally recognized sustainability and life cycle assessment consultancy. Minviro estimates that for every kilogram of LHM being produced, the RecycLiCo process would potentially release 3.3 kg of CO2 equivalent emissions, far below the estimated 12.7 kg of CO2 emissions, based on industry averages, for traditional mining and refining. This means that on average, for every 100,000 new electric vehicle (EV) battery packs produced using LHM from the RecycLiCo process, potentially 40,570 tonnes - roughly the weight of 300 blue whales - of CO2 equivalent emissions may be avoided.
Willow Biosciences Inc has provided an update on cannabigerol (CBG), the company's first commercialized functional ingredient in its portfolio. "As we expand our portfolio of products and partnerships, we also remain committed to maximizing the value of our first functional ingredient, CBG, through continued development, operational improvements, and marketing efforts," Willow's interim president and CEO Dr Peter Seufer-Wasserthal said in a statement. "We remain optimistic on the future opportunity for CBG and other cannabinoids and will be well-positioned to capture that value as the markets develop," he added.
Solstice Gold Corp has announced the closing of its previously announced private placement financing for gross proceeds of approximately $2.7 million, representing an upsize from the previously anticipated gross proceeds of $1.1 million. The offering saw the issuance of 12,766,667 HD units at a price of $0.12 per HD unit, each comprised of one common share of the company and one warrant exercisable for one common share at $0.17 for 18 months from the closing date; and 8,707,216 NFT units at a price of $0.135 per NFT unit, each comprised of one common share qualifying as a flow-through (FT) share for purposes of the Income Tax Act (Canada) and a half warrant on the same terms as the warrants in the HD units. The company also announced that Kevin Reid will step down as a director of the company effective September 30, 2022, due to personal time constraints but will remain the largest shareholder of the company. Under the offering, Reid acquired $1.0 million of HD units at a price of $0.12 per unit, increasing his ownership in the company to approximately 16.5%. "Kevin has been a strong supporter and major shareholder of Solstice since its inception, including having served as a Board member since 2020," said David Adamson, chairman of Solstice in a statement.
Bhang Inc said it has partnered with Hoodie Analytics, one of the largest and most impactful platforms in the cannabis space, to streamline its sales insights and strategies. Hoodie Analytics tracks over 4 million daily unique offers in over 8,500 dispensaries in the US and Canada and tracks sales metrics such as pricing, promotion, stocking status, distribution and share of shelf. "Complex, strategic decisions require more than just accurate data over a certain period. We need real-time analytics to understand where and when we can make a difference," Wes Eder, Global VP of Revenue for Bhang said in a statement.
Ridgeline Minerals Corp has provided an update on ongoing drill programs and exploration activities at the company's Selena and Swift projects in Nevada and its Robber Gulch project in Idaho. Ridgeline vice president of exploration Mike Harp said the company is excited to see substantial drill programs being completed at both Selena and Swift this fall, with drilling at Swift 100% funded by partners at Nevada Gold Mines. “At our wholly-owned Selena project, we continue to discover new mineralized zones as a result of our team's systematic approach to exploring this complex CRD system. Selena exhibits incredible exploration upside and our 3Q 2022 drill campaign is an important first step towards expanding the shallow mineralized footprint across multiple zones as we advance the project to a maiden resource," Harp said in a statement.
Mindset Pharma Inc, which is focused on creating novel psychedelic and non-psychedelic medications to treat neuropsychiatric and neurological disorders, revealed that through its discovery work, it has identified three additional families of highly novel, non-tryptamine, next-generation psychedelic compounds. While much of the industry focus has been on classic psychedelic drugs, Mindset noted that it has purposefully expanded its discovery efforts beyond the tryptamine drug class - psilocybin and N,N-Dimethyltryptamine (DMT) - into new, innovative chemical structures in order to develop superior neuropsychiatric medications. Using a fragment-based drug discovery (FBDD) method combined with a highly focused medicinal chemistry strategy, the Toronto-based drug discovery company’s scientists designed and developed three new, chemically distinct, small molecule non-tryptamine scaffolds, Families 6, 7 and 8. Mindset has filed provisional patent applications on these families, with favorable Freedom to Operate (FTO) searches.
Silver Range Resources Ltd has revealed that it is set to option its Bellehelen silver-gold project in central Nevada, USA, to a private British Columbia (BC) company. The deal, expected to be formally agreed within 45 days, will see the BC firm pay C$300,000 in cash and 200,000 shares over four years. It will also receive a 2% net smelter return (NSR), which is buyable down to 1% for C$1million. There is a US$2 per ounce (gold-equivalent) payment on any resource, which is defined at the asset. The company must also complete a listing on a Canadian stock exchange by May 30 next year.
Adastra Holdings Ltd said it has positioned itself for future growth, having received a key controlled drug and substances dealer's license on August 24 this year which allows the company to process psilocybin and psilocin, the active compounds derived from psychedelic mushrooms. "This is another significant step forward in the next phase of Adastra's goal to become a leader in alternative, plant-based treatments and remedies for physical, mental health and optimal functioning," noted Michael Forbes, CEO of Adastra, in a statement. "We believe our dealer's license offers Adastra a preemptive advantage over our peers, by having our processes for the extraction and formulation of psilocybin validated before any future potential changes in regulations, enabling us to stay ahead," he added.
Aftermath Silver Limited has reported impressive final assay results from the 2021-2022 diamond drill program at its Berenguela silver-copper-manganese project in southern Peru. The Vancouver-based company said 63 holes were completed during the program for a total of 6,168 meters (m) of core drilling. Aftermath's technical team is incorporating the drill results into a revised geological interpretation of the Berenguela mineralization which will be used to complete a new NI 43-101 compliant mineral resource estimate later in 2022. Historical mapping and resource modelling show that the mineralization extends 1,300m along strike (including a 100m length zone with historic open-pit mining but no drilling) with a width of 200m to 400m, said the company.
PyroGenesis Canada Inc said a tier-one North American global aerospace company in September will be conducting an in-person powder production audit at its metal powder production facility in Montreal as part of a previously announced qualification agreement. The company said the audit is part of the final phase of the qualification process which has spanned over 18 months of investigative rigor by the client. This portion of the audit will consist mainly of a facilities and operations assessment, during which PyroGenesis’ technicians and operators will demonstrate the reliability of the company’s cutting-edge metal powder production facility and work instruction processes, the company said.
Irwin Naturals Inc has announced that its Irwin Naturals Cannabis, Inc subsidiary has signed a licensing agreement with 42 Degrees Processing LLC to produce and distribute Irwin Naturals THC products in Michigan, one of the fastest-growing cannabis markets in the country. The nutraceutical company said under the agreement, 42 Degrees Processing will augment Irwin Naturals products with THC and make them available to the about 1,000 dispensaries currently operating in Michigan. “Michigan is a significant step in what is becoming a sprint to put Irwin Naturals THC products on the shelves of dispensaries in all 38 states where cannabis is legalized,” Irwin Naturals CEO Klee Irwin said in a statement.
American Resources Corporation said it has agreed to sell exclusive patent rights in carbon nanostructure and graphene technology to Novusterra Inc for US$16 million worth of Novusterra stock, paid in Class A common shares. Also, members of American Resources will take over the management of Novusterra as well as join its board of directors. American Resources said it intends to dividend most of the shares that it receives through this transaction to its underlying investors at or before Novusterra's public offering, which is still subject to exchange and US Securities Exchange Commission approvals.
Guardforce AI Co Ltd has announced a series of appointments to form a revamped management team to support its accelerated growth in the robotics and information security markets. Firstly, it said CEO Lei (Olivia) Wang has been appointed chairman of the board, while continuing to serve in her current role. She replaces Wing Khai (Terence) Yap, who has resigned to pursue other interests, the company added. Lin Jia, Guardforce’s head of research and development since May, has been named the company’s president. He previously served as COO and CTO at Shenzhen Intelligent Guardforce Robot Co Ltd, a leading robotics company that specializes in the design, manufacturing, and application of service robots in mainland China.
Kontrol Technologies Corp said it has struck a credit agreement worth up to C$50 million, which will streamline its balance sheet and add capacity for future acquisitions. The lender is a Schedule 1 bank, the company noted, and the credit facilities consist of a loan of up to C$20 million, a revolving credit facility of up to C$10 million, and a so-called accordion feature of up to C$20 million. "These facilities will streamline the balance sheet by consolidating debt and lowering the company's cost of capital," said Paul Ghezzi, the CEO of Kontrol, in a statement. "It will also add capacity for M&A that provides financial flexibility to allow capital deployment in a timely manner as we execute on potential acquisitions."
Electric Royalties Ltd said its board of directors has adopted a shareholder rights plan to help ensure the fair treatment of all Electric Royalties shareholders in connection with any take-over bid for the outstanding common shares of the company. The plan is effective immediately but is subject to ratification by shareholders of the company at its 2022 annual general meeting. If ratified, the plan would have a term of three years. The plan is similar to rights plans adopted by other Canadian companies and ratified by their shareholders. It was not adopted in response to any specific proposal or intention to acquire control of the company. The company's board of directors believes that the plan benefits shareholders by providing a substantially greater opportunity to protect the interests of all shareholders in the event that the company is put in play through a hostile takeover bid.
VR Resources Ltd said it has closed the first tranche of its previously announced non-brokered private placement, consisting of 6,443,750 units at a price of 16 cents per unit for total gross proceeds of $1,031,000. Each unit consists of one common share of the company and one-half of a common share purchase warrant. Each whole warrant will entitle the holder to acquire one additional common share at an exercise price of 25 cents per common share for a period of 18 months from the closing date of the financing. In connection with the financing, the company paid cash fees of $11,940 to certain finders. The securities that were issued under the financing are subject to a four-month hold period under Canadian securities law. VR said it will use the net proceeds of the financing for its mineral exploration business, including active exploration on various mineral properties held in Ontario, Canada, and Nevada, USA.
Nevada Silver Corporation said it has closed its previously-announced sale of securities of its indirectly wholly-owned US subsidiary, North Star Manganese Inc (NSM). NSM sold a total of 3,160,233 shares of NSM at a price of US$0.25 per share for gross proceeds of US$790,058.23. As a result of the NSM financing, the outstanding shares of NSM have increased to 33,160,233 shares of NSM common stock, with the company's indirect shareholding reducing to approximately 90.5%. The NSM financing has received the final approval of the TSX Venture Exchange. Proceeds from the NSM financing will be used to advance technical studies at the Emily Manganese project and for general working capital. No commissions or fees were paid in connection with the NSM financing.
Think Research Corporation announced that it has granted 450,000 restricted share units (RSU) to key employees of the company under its Omnibus Equity Incentive Plan which will vest in one year. Think also announced that on June 22, 2022, it granted 215,960 RSUs to certain non-executive directors of the company that will vest on September 1, 2022. Additionally, on June 22, 2022, the company granted 218,531 deferred share units (DSU) to certain non-executive directors of the company under its Omnibus Equity Incentive Plan. Each DSU represents the right to receive one common share upon the holder of such DSU ceasing to be employed as an officer, employee or director of the company or any of its subsidiaries.
Co-Diagnostics Inc has announced that it will be hosting a booth at the upcoming Medical Fair Asia 2022 trade show held August 31-September 2, 2022 at the Marina Bay Sands in Singapore. The event, Southeast Asia's most established trade fair for the medical and healthcare industry is expected to host over 14,000 visitors from 70 counties and regions, and is open to medical specialists, business executives in the medical trade and other relevant professionals involved in the industry. Co-Diagnostics expects that the show will provide opportunities for company representatives and distributors to introduce Co-Diagnostics products to a wide array of international customers, and to strengthen the company's distributor outreach across Asia. More details about the conference, including in-person and virtual registration, is available via the following link: www.medicalfair-asia.com. Attendees interested in learning more about the company and its products, including its upcoming point-of-care and at-home rapid PCR diagnostics platform, are invited to visit Booth #2G01.
Zynerba Pharmaceuticals Inc has announced the acceptance of an oral presentation at The Society for the Study of Behavioural Phenotypes (SSBP) 24th International Research Symposium, which will be held in Oslo, Norway, September 8-10, 2022. The oral presentation is titled 'An Open-Label, Tolerability and Efficacy Study of ZYN002 (Cannabidiol) Administered as a Transdermal Gel to Children and Adolescents with 22q11.2 Deletion Syndrome (INSPIRE)' and will be delivered on September 8, 2022, at 3.30pm CEST / 9.30am EDT. A copy of the presentation slides will be made available on the Zynerba corporate website following the presentation at https://zynerba.com/publications/. Additional meeting information can be found on the SSBP website at https://ssbp.org.uk/.
Numinus Wellness Inc has announced that it will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022. Numinus will present on Tuesday, September 13, 2022, at 9.00am ET. Interested parties can register to attend the event via the following link: https://hcwevents.com/annualconference/. For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, interested parties can send an email to KCSA Strategic Communications numinusir@kcsa.com.
Vyant Bio Inc has announced that it will be presenting at the H.C. Wainwright 24th Annual Global Investment Conference. The event is being held from September 12-14, 2022. During the presentation, Vyant Bio's CEO Jay Roberts will discuss key milestones and achievements on the scientific, business, and strategic front. Registered attendees can access the recorded presentation on-demand (24x7) for 90 days. Institutional investors who would like to listen to the company's presentation, can click on the following link https://hcwevents.com/annualconference/ to register for the conference. Once registration is confirmed, partipipants will be able to request a one-on-one meeting with the company via the conference website. Vyant Bio will also be available for outside 1:1 meetings in New York City during and after the H.C. Wainwright Global Investment Conference and interested parties can contact Scott Powell at info@skylineccg.com or call (646) 893-5835 x2 for scheduling. The presentation slides will also be available in the Investors' section of the Vyant Bio website.
OTC Markets Group Inc, the operator of regulated markets for 12,000 US and international securities, has announced that HealthBeacon PLC, an Irish digital therapeutics company, has qualified to trade on the OTCQX Best Market and begins trading today under the symbol HBCNF. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. "We are very pleased to begin trading on the OTCQX Market, an important milestone for HealthBeacon that provides an opportunity to grow our US investor base," said HealthBeacon CEO and co-founder, Jim Joyce. "Fundamentally, this development enables greater awareness and increased visibility of our stock in one of our core markets, but we also believe it will provide improved liquidity and, consequently, enhance shareholder value. HealthBeacon's mission is to become the world's leading digital therapeutics platform for injectable medications. This is yet another step on our journey, as a listed business, towards connecting people to better health through sustainable, digitally enabled solutions."
OTC Markets Group Inc, the operator of regulated markets for 12,000 US and international securities, has announced that Montage Gold Corp, a gold exploration and development company focused in Cote d'Ivoire, has qualified to trade on the OTCQX Best Market and has today upgraded from the Pink market under the symbol MAUTF. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws.
OTC Markets Group Inc, the operator of regulated markets for 12,000 US and international securities, has announced that POSaBIT Systems Corporation, a payments infrastructure provider for the cannabis industry, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTCQB Venture Market under the symbol POSAF. The OTCQX Market provides investors with a premium US public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.